(Q63318733)
Statements
Phase II, Open-label, Non-randomized Study of Nab-paclitaxel for the Neoadjuvant Treatment of Patients With Stage II and III Luminal Breast Cancer (English)
0 references
April 2012
0 references
December 2012
0 references
78
0 references
18 year
0 references